CN104041811B - A kind of Taurine improving male's sexual and semen quality - Google Patents

A kind of Taurine improving male's sexual and semen quality Download PDF

Info

Publication number
CN104041811B
CN104041811B CN201410264589.6A CN201410264589A CN104041811B CN 104041811 B CN104041811 B CN 104041811B CN 201410264589 A CN201410264589 A CN 201410264589A CN 104041811 B CN104041811 B CN 104041811B
Authority
CN
China
Prior art keywords
compound preparation
taurine
parts
semen quality
semen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410264589.6A
Other languages
Chinese (zh)
Other versions
CN104041811A (en
Inventor
胡建民
杨建成
林树梅
冯颖
吴高峰
秦臻
杨群辉
吕秋凤
栾新红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenyang Agricultural University
Original Assignee
Shenyang Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenyang Agricultural University filed Critical Shenyang Agricultural University
Priority to CN201410264589.6A priority Critical patent/CN104041811B/en
Publication of CN104041811A publication Critical patent/CN104041811A/en
Application granted granted Critical
Publication of CN104041811B publication Critical patent/CN104041811B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

本发明涉及保健食品领域,具体提供了一种改善男性性功能和精液品质的牛磺酸复合制剂,所述复合制剂的有效成分由以下重量配比的原料组成:牛磺酸5~60份,精氨酸10~40份、锌5-30份和维生素C5~30份。本发明所述复合制剂,经临床试验证明对机体无毒害作用,可安全使用。本发明所述复合制剂具有抗氧化、抗疲劳、提高免疫力的功能,尤其是在提高男性性功能和精液品质方面效果显著。The invention relates to the field of health food, and specifically provides a taurine compound preparation for improving male sexual function and semen quality. The active ingredients of the compound preparation are composed of the following raw materials in the weight ratio: 5-60 parts of taurine, 10-40 parts of arginine, 5-30 parts of zinc and 5-30 parts of vitamin C. The compound preparation of the invention has been proved by clinical tests to have no toxic effect on the body and can be used safely. The compound preparation of the invention has the functions of anti-oxidation, anti-fatigue, and improving immunity, especially in improving male sexual function and semen quality.

Description

一种改善男性性功能和精液品质的牛磺酸复合制剂A taurine compound preparation for improving male sexual function and semen quality

技术领域technical field

本发明涉及保健食品领域,具体涉及一种改善男性性功能和精液品质的牛磺酸复合制剂。The invention relates to the field of health food, in particular to a taurine compound preparation for improving male sexual function and semen quality.

背景技术Background technique

当前,男性生殖健康是全社会关注的热点问题。联合国特别规划署明确指出:重视生殖健康和生殖健康保健服务是人类社会文明进步的必然趋势。1994年9月在开罗召开的“国际人口与发展大会”上,180多个国家的代表一致认识到男性生殖健康的重要性,决定把“生殖健康”作为“全球最优先考虑的问题”列入大会所制订的“行动纲领”之中,要求各国政府首脑对此作出承诺,保证“在21世纪实现人人获得生殖健康保健服务”。世界卫生组织(WHO)也决定把21世纪定为“生殖健康世纪”。我国计生委2000年做出决定,将每年的10月28日设立为“男性健康日”,以提醒全社会关注男性健康,尤其是男性生殖健康。男性生殖健康研究的重点是防止生殖机能衰退,提高生殖性能。At present, male reproductive health is a hot issue of concern to the whole society. The United Nations Special Program clearly pointed out: Emphasis on reproductive health and reproductive health care services is an inevitable trend in the progress of civilization in human society. At the "International Conference on Population and Development" held in Cairo in September 1994, representatives of more than 180 countries unanimously recognized the importance of male reproductive health, and decided to include "reproductive health" as "the most important issue in the world" In the "Action Plan" formulated by the General Assembly, the heads of governments of all countries are required to make a commitment to ensure that "everyone has access to reproductive health care services in the 21st century". The World Health Organization (WHO) has also decided to designate the 21st century as the "reproductive health century". my country's Family Planning Commission made a decision in 2000 to set October 28th as "Men's Health Day" to remind the whole society to pay attention to men's health, especially male reproductive health. The focus of male reproductive health research is to prevent reproductive function decline and improve reproductive performance.

男性生殖机能主要包括性功能和精液品质两方面的评价。性功能指性活动的能力,是衡量男性生殖机能强弱的主要指标。性活动包括阴茎勃起、插入、射精等几个环节,其中阴茎勃起是产生正常性活动的基础。阴茎勃起过程表现为在性刺激引导下,海绵体内小动脉和海绵窦壁内的平滑肌松弛,流入海绵体的血流增加,海绵体内压升高,压迫白膜下静脉丛和穿支静脉后使海绵体流出静脉血减少,勃起发生。在此过程中,普遍认为非胆碱能、非肾上腺素能神经末梢的激活和释放一氧化氮(NO)增加促进小动脉和海绵体平滑肌舒张是导致阴茎勃起的主要机制。雄激素是维持性欲必不可少的一种激素,并可通过中枢和外周两方面调控阴茎勃起,且可易化勃起。精液品质包括精子数量、活动率、活率、畸形率和顶体完整率等指标,精液品质的高低直接影响男性的生殖能力,精液品质低劣是导致当今男性不育的主要因素之一。男性生殖机能受遗传、环境、饮食和年龄等因素的影响。Male reproductive function mainly includes the evaluation of sexual function and semen quality. Sexual function refers to the ability of sexual activity, which is the main index to measure the strength of male reproductive function. Sexual activity includes penile erection, penetration, ejaculation, etc., among which penile erection is the basis for normal sexual activity. The process of penile erection shows that under the guidance of sexual stimulation, the small arteries in the cavernous body and the smooth muscle in the wall of the cavernous sinus relax, the blood flow into the cavernous body increases, the pressure in the cavernous body increases, and the venous plexus of the subwhite membrane and the perforating vein are compressed. The outflow of venous blood from the cavernous bodies decreases and erections occur. During this process, it is generally believed that the activation of non-cholinergic and non-adrenergic nerve endings and the increase in the release of nitric oxide (NO) to promote the relaxation of arterioles and cavernous smooth muscle are the main mechanisms leading to penile erection. Androgen is an essential hormone to maintain sexual desire, and can regulate penile erection through both central and peripheral aspects, and can facilitate erection. Semen quality includes indicators such as sperm count, motility rate, motility rate, deformity rate, and acrosome integrity rate. The quality of semen directly affects the reproductive ability of men. Poor semen quality is one of the main factors leading to male infertility today. Male reproductive function is affected by factors such as heredity, environment, diet and age.

目前,虽然已有提高男性性功能和精液品质的药物或配合制剂出现,但这些药物配方繁杂,针对性差,效果不够理想,主效药物也不够突出,而且长期服用会出现一定的副作用。At present, although there have been drugs or compound preparations to improve male sexual function and semen quality, these drugs have complicated formulas, poor pertinence, unsatisfactory effects, and the main effect drugs are not prominent enough, and certain side effects will occur after long-term use.

发明内容Contents of the invention

为了解决现有技术中存在的问题,本发明的目的在于提供一种配方简单、安全、无副作用的能明显改善男性性功能并提高精液品质的牛磺酸复合制剂。In order to solve the problems in the prior art, the object of the present invention is to provide a taurine compound preparation with simple formula, safety and no side effects, which can obviously improve male sexual function and improve semen quality.

为了实现本发明目的,本发明提供一种改善男性性功能和精液品质的牛磺酸复合制剂,其特征在于,所述复合制剂的有效成分由以下重量配比的原料组成:牛磺酸5~60份,精氨酸10~40份、锌5-30份和维生素C5~30份。In order to achieve the purpose of the present invention, the present invention provides a taurine compound preparation for improving male sexual function and semen quality, which is characterized in that the active ingredients of the compound preparation are composed of the following raw materials in weight ratio: taurine 5~ 60 parts, 10-40 parts of arginine, 5-30 parts of zinc and 5-30 parts of vitamin C.

作为优选,所述复合制剂的有效成分由以下重量配比的原料组成:牛磺酸20~60份,精氨酸15~35份、锌15~25份和维生素C10~20份。Preferably, the active ingredients of the compound preparation are composed of the following raw materials in weight ratio: 20-60 parts of taurine, 15-35 parts of arginine, 15-25 parts of zinc and 10-20 parts of vitamin C.

更为优选,所述复合制剂的有效成分由以下重量配比的原料组成:牛磺酸50份,精氨酸25份、锌20份和维生素C15份。More preferably, the active ingredients of the compound preparation consist of the following raw materials in weight ratio: 50 parts of taurine, 25 parts of arginine, 20 parts of zinc and 15 parts of vitamin C.

上述有效成分的作用如下:The effects of the above active ingredients are as follows:

牛磺酸是机体生殖腺和生殖细胞中含量最丰富的游离氨基酸之一,对机体生殖机能具有重要的作用。牛磺酸是精子活力激动剂,在精液中添加牛磺酸可增加精子体外存活时间,保持精子的正常运动;在精液稀释液中添加牛磺酸,可提高冷冻精液中精子的成活率,增加精子活力。睾丸组织可生物合成牛磺酸,机体补充牛磺酸可促进睾酮的分泌,显著提高精液品质;并可提高机体内NO的含量,显著增强老龄雄性大鼠的性功能。Taurine is one of the most abundant free amino acids in the gonads and germ cells of the body, and plays an important role in the reproductive function of the body. Taurine is a sperm motility agonist. Adding taurine to semen can increase the survival time of sperm in vitro and maintain the normal movement of sperm; adding taurine to semen diluent can increase the survival rate of sperm in frozen semen and increase sperm motility. Testicular tissue can biosynthesize taurine. Supplementing the body with taurine can promote the secretion of testosterone and significantly improve the quality of semen; it can also increase the content of NO in the body and significantly enhance the sexual function of aged male rats.

精氨酸是精子蛋白的主要成分,可促进精子的生成和代谢,并可作为精子运动的能源。精氨酸是机体内NO生物合成的前体,而NO不仅参与睾丸微循环的调节,睾酮的分泌,而且可促进和调节精子的发生和活力。Arginine is the main component of sperm protein, which can promote the production and metabolism of sperm, and can be used as an energy source for sperm movement. Arginine is the precursor of NO biosynthesis in the body, and NO not only participates in the regulation of testicular microcirculation and the secretion of testosterone, but also promotes and regulates spermatogenesis and motility.

锌是人体必需的微量元素,在男性前列腺、睾丸及精液中含量较高,以酶的形式参与性腺的发育、精子的生成、成熟、获能和顶体反应等过程。锌可影响下丘脑-垂体-睾丸轴的功能,促进睾酮的分泌,进而影响性腺发育和精子生成。锌可通过抗脂质过氧化作用保护精子,通过调节精子磷脂代谢调节精子活力。Zinc is an essential trace element for the human body, and its content is relatively high in the male prostate, testis and semen. It participates in the development of gonads, sperm production, maturation, capacitation and acrosome reaction in the form of enzymes. Zinc can affect the function of the hypothalamus-pituitary-testis axis, promote the secretion of testosterone, and then affect the development of gonads and sperm production. Zinc can protect sperm by anti-lipid peroxidation, and regulate sperm motility by regulating sperm phospholipid metabolism.

维生素C又称抗坏血酸,一种良好抗氧化剂,在人体内参与许多重要的代谢。不育男性精液中维生素C水平显著降低。通过在食物中补充维生素C能提高25岁以上男性精子的存活力和运动力,增加成熟精子数,减少精子畸形率。Vitamin C, also known as ascorbic acid, is a good antioxidant and participates in many important metabolisms in the human body. Vitamin C levels in the semen of infertile men were significantly lower. Supplementing vitamin C in food can improve the viability and motility of sperm in men over 25 years old, increase the number of mature sperm, and reduce the rate of sperm deformity.

进一步地,前述复合制剂的剂型为片剂、胶囊剂、颗粒剂和冲剂。Further, the dosage forms of the aforementioned compound preparations are tablets, capsules, granules and granules.

作为优选,前述复合制剂的剂型为片剂和胶囊剂。所述复合制剂的具体制备方法如下:①按比列称取原料,混合,备用;②装入胶囊;或者与片剂常用辅料(淀粉、植物纤维素等)混合,压成片剂。As a preference, the dosage forms of the aforementioned compound preparations are tablets and capsules. The specific preparation method of the compound preparation is as follows: 1. Weigh the raw materials according to the ratio, mix them, and set aside; 2. Pack them into capsules; or mix them with common auxiliary materials for tablets (starch, plant cellulose, etc.), and press them into tablets.

其中,所述复合制剂中的有效成分的质量百分数不低于80%。Wherein, the mass percentage of the active ingredients in the compound preparation is not less than 80%.

本发明还提供了所述复合制剂在改善男性性功能上的应用。The invention also provides the application of the compound preparation in improving male sexual function.

本发明还提供了所述复合制剂在提高精液品质上的应用。The invention also provides the application of the compound preparation in improving the quality of semen.

本发明的有益效果在于:The beneficial effects of the present invention are:

本发明所述的改善男性性功能和精液品质的牛磺酸复合制剂配方简单,经临床试验证明对机体无毒害作用,可安全使用。本发明所述复合制剂具有抗氧化、抗疲劳、提高免疫力的功能,尤其是在提高男性性功能和精液品质方面效果显著。The taurine compound preparation for improving male sexual function and semen quality described in the present invention has a simple formula, has no toxic effect on the body as proved by clinical tests, and can be used safely. The compound preparation of the invention has the functions of anti-oxidation, anti-fatigue, and improving immunity, especially in improving male sexual function and semen quality.

具体实施方式detailed description

以下实施例用于说明本发明,但不用来限制本发明的范围。The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention.

实施例1Example 1

将牛磺酸500mg、精氨酸250mg、锌200mg和维生素C150mg混合,装入胶囊,每粒药粉1g。Mix 500mg of taurine, 250mg of arginine, 200mg of zinc and 150mg of vitamin C, pack into capsules, 1g of each powder.

实施例2Example 2

将牛磺酸200mg、精氨酸350mg、锌150mg和维生素C200mg混合,装入胶囊,每粒药粉1g。Mix 200mg of taurine, 350mg of arginine, 150mg of zinc and 200mg of vitamin C, put into capsules, 1g of each medicine powder.

实施例3Example 3

将牛磺酸600mg、精氨酸150mg、锌250mg、维生素C100mg混合,装入胶囊,每粒药粉1g。Mix 600mg of taurine, 150mg of arginine, 250mg of zinc, and 100mg of vitamin C, and pack into capsules, 1g of each medicine powder.

实施例4Example 4

将牛磺酸50mg、精氨酸400mg、锌300mg和维生素C300mg混合,装入胶囊,每粒药粉1g。Mix 50mg of taurine, 400mg of arginine, 300mg of zinc and 300mg of vitamin C, put into capsules, 1g of each powder.

实施例5Example 5

将牛磺酸600mg、精氨酸100mg、锌50mg和维生素C50mg混合,装入胶囊,每粒药粉1g。Mix 600mg of taurine, 100mg of arginine, 50mg of zinc and 50mg of vitamin C, put into capsules, 1g of each powder.

为了验证本发明提供的用于提高男性性功能和精液品质的牛磺酸复合制剂的效果,本发明人对上述实施例1、2、3、4和5制成的药剂进行了临床疗效验证,实验方法和结果如下。In order to verify the effect of the taurine compound preparation for improving male sexual function and semen quality provided by the present invention, the present inventor has carried out clinical curative effect verification to the medicament that above-mentioned embodiment 1,2,3,4 and 5 make, The experimental methods and results are as follows.

1.试验方法1. Test method

1.1治疗勃起功能障碍试验1.1 Treatment of erectile dysfunction trials

选择120例临床确诊勃起功能障碍(ED)的患者进行试验,随机分为6组,每组20例,其中第1组为对照组,给予淀粉胶囊制剂;第2、3、4、5、6组为试验组1、2、3、4、5,分别给予实施例1、2、3、4、5胶囊制剂,每人每天分2次(早晚各1次)服用胶囊制剂,每次3粒,连续服用2个月,问询其治疗效果,治疗效果分为三个级别:①疗效显著(房事前阴茎能够正常勃起,并能进行性生活,而且感觉持续时间比未患病前延长),②治疗有效(房事前阴茎能够正常勃起,并能进行性生活,但感觉举而不坚),③无效(房事前阴茎部能够正常勃起或勃起时间很短,仍不能进行正常性生活)。Select 120 cases of patients with clinically diagnosed erectile dysfunction (ED) to carry out the test, and randomly divide them into 6 groups, 20 cases in each group, wherein the first group is the control group, which is given starch capsule preparation; the second, third, fourth, fifth, and sixth Group is test group 1,2,3,4,5, gives embodiment 1,2,3,4,5 capsule preparation respectively, every day divides 2 times (morning and evening each 1 time) and takes capsule preparation, each time 3 capsules , taking it continuously for 2 months, and inquiring about its therapeutic effect. The therapeutic effect is divided into three levels: ① significant curative effect (the penis can be erected normally before intercourse, and can have sex, and the feeling lasts longer than before the disease), ②The treatment is effective (the penis can be erected normally before intercourse, and can have sexual life, but the feeling is not firm), ③ineffective (the penis can be erected normally or the erection time is very short before intercourse, and normal sexual life is still not possible).

1.2治疗精液品质低下试验1.2 Treatment of low quality semen test

选择120例临床确证单纯精液品质低下患者(非精索静脉曲张和先天性疾病导致,精子数量低于2000万/ml、精子活率<30%。精子活力A级<10%或A级+B级<25%)的患者进行试验,随机分为6组,每组20例,其中第1组为对照组,给予淀粉胶囊制剂;第2、3、4、5、6组为试验组1、2、3、4、5,分别给予实施例1、2、3、4、5胶囊制剂,每人每天分2次(早晚各1次)服用胶囊制剂,每次3粒,连续服用4个月,之后采集精液,进行精液品质检查。治疗效果分三个级别:治疗显著(精子数量>4000万/ml、精子活率>50%。精子活力A级>20%或A级+B级>40%),治疗有效(精子数量、精子活率、精子活力中最少有一个指标比治疗前提高),治疗无效(精液品质无改善或下降)。Select 120 patients with clinically confirmed low semen quality (not caused by varicocele and congenital diseases, sperm count less than 20 million/ml, sperm motility <30%. Sperm motility grade A <10% or grade A+B Grade <25%) patients were tested, randomly divided into 6 groups, 20 examples in each group, wherein the first group was the control group, given starch capsule preparation; the second, third, fourth, fifth and sixth groups were the experimental groups 1, 2, 3, 4, 5, give respectively the capsule preparation of embodiment 1, 2, 3, 4, 5, and each person takes the capsule preparation in 2 times (morning and evening respectively) every day, 3 capsules each time, taking continuously for 4 months After that, the semen is collected and the quality of the semen is checked. The treatment effect is divided into three levels: significant treatment (sperm count > 40 million/ml, sperm motility rate > 50%. Sperm motility grade A > 20% or grade A + B > 40%), effective treatment (sperm count, sperm motility Motility rate, sperm motility at least one index is higher than before treatment), treatment is ineffective (no improvement or decline in semen quality).

2.试验结果2. Test results

2.1勃起功能障碍治疗效果2.1 Treatment effect of erectile dysfunction

牛磺酸复合制剂对勃起功能障碍治疗效果见表1,由表1可见,本发明提供的牛磺酸符合制剂对于治疗ED有良好的效果,且以实施例1效果最好,有效率达到90%。Taurine compound preparation is shown in Table 1 to the therapeutic effect of erectile dysfunction, as can be seen from Table 1, the taurine accordant preparation provided by the present invention has good effect for the treatment of ED, and with the best effect of Example 1, the effective rate reaches 90%. %.

表1牛磺酸复合制剂治疗勃起功能障碍效果(单位:人,n=20)The effect of table 1 taurine compound preparation on treating erectile dysfunction (unit: people, n=20)

组别group 疗效显著Significant effect 治疗有效effective treatment 治疗无效Ineffective treatment 对照组control group 00 22 1818 试验组1Test group 1 1212 66 22 试验组2Test group 2 77 99 44 试验组3Test group 3 88 88 44 试验组4Test group 4 66 66 88 试验组5Test group 5 55 88 77

2.2精液品质低下治疗效果2.2 Treatment effect of low semen quality

牛磺酸复合制剂对精液品质低下治疗效果见表2,由表2可见,本发明提供的牛磺酸符合制剂对于治疗精液品质低下有良好的效果,且以实施例1效果最好,有效率达到90%。The taurine compound preparation is shown in Table 2 to the low therapeutic effect of semen quality, as can be seen from Table 2, the taurine conforming preparation provided by the present invention has good effect for the treatment of low semen quality, and the effect is the best with embodiment 1, effective rate up to 90%.

表2牛磺酸复合制剂治疗精液品质低下效果(单位:人,n=20)Table 2 The effect of taurine compound preparation on treating low semen quality (unit: person, n=20)

组别group 疗效显著Significant effect 治疗有效effective treatment 治疗无效Ineffective treatment 对照组control group 11 33 1616 试验组1Test group 1 1313 55 22 试验组2Test group 2 99 77 33 试验组3Test group 3 77 1010 33 试验组4Test group 4 55 88 77 试验组5Test group 5 66 77 77

虽然,上文中已经用一般性说明及具体实施方案对本发明作了详尽的描述,但在本发明基础上,可以对之作一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。Although the present invention has been described in detail with general descriptions and specific embodiments above, it is obvious to those skilled in the art that some modifications or improvements can be made on the basis of the present invention. Therefore, the modifications or improvements made on the basis of not departing from the spirit of the present invention all belong to the protection scope of the present invention.

Claims (4)

1.一种改善男性性功能和精液品质的牛磺酸复合制剂,其特征在于,所述复合制剂的有效成分由以下重量配比的原料组成:牛磺酸50份,精氨酸25份、锌20份和维生素C15份。1. a taurine compound preparation improving male sexual function and semen quality, is characterized in that, the active ingredient of described compound preparation is made up of the raw material of following weight ratio: 50 parts of taurine, 25 parts of arginine, 20 parts of zinc and 15 parts of vitamin C. 2.根据权利要求1所述的复合制剂,其特征在于,所述复合制剂的剂型为片剂、胶囊剂、颗粒剂和冲剂。2. The compound preparation according to claim 1, characterized in that, the dosage form of the compound preparation is tablet, capsule, granule and electuary. 3.根据权利要求2所述的复合制剂,其特征在于,所述复合制剂的剂型为片剂和胶囊剂。3. compound preparation according to claim 2, is characterized in that, the dosage form of described compound preparation is tablet and capsule. 4.根据权利要求2所述的复合制剂,其特征在于,所述复合制剂中的有效成分的质量百分数不低于80%。4. The compound preparation according to claim 2, characterized in that, the mass percentage of the active ingredients in the compound preparation is not less than 80%.
CN201410264589.6A 2014-06-13 2014-06-13 A kind of Taurine improving male's sexual and semen quality Active CN104041811B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410264589.6A CN104041811B (en) 2014-06-13 2014-06-13 A kind of Taurine improving male's sexual and semen quality

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410264589.6A CN104041811B (en) 2014-06-13 2014-06-13 A kind of Taurine improving male's sexual and semen quality

Publications (2)

Publication Number Publication Date
CN104041811A CN104041811A (en) 2014-09-17
CN104041811B true CN104041811B (en) 2016-01-20

Family

ID=51495678

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410264589.6A Active CN104041811B (en) 2014-06-13 2014-06-13 A kind of Taurine improving male's sexual and semen quality

Country Status (1)

Country Link
CN (1) CN104041811B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106074598A (en) * 2016-06-14 2016-11-09 奥格生物技术(六安)有限公司 A kind of organic chelated microelement composition of compound recipe treating unusual semen and male infertility disease and preparation method thereof
US20220160670A1 (en) * 2017-12-06 2022-05-26 Laboratoire Des Granions Composition comprising l-carnitine for the treatment of male infertility

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100419060C (en) * 2006-04-17 2008-09-17 陈坤鑫 Vigorous wine and preparation method thereof
CN101152199A (en) * 2006-09-27 2008-04-02 傅海洋 Health care food for improving sexual function of men and women

Also Published As

Publication number Publication date
CN104041811A (en) 2014-09-17

Similar Documents

Publication Publication Date Title
JP2012140437A (en) Use of pregnane glycoside in treatment/management of obesity, obesity-related disorder, and other disorder
CN101152199A (en) Health care food for improving sexual function of men and women
JP6425106B2 (en) Method for producing a herbal medicine composition for skin cooling sensation using jaundice extract
CN104041811B (en) A kind of Taurine improving male&#39;s sexual and semen quality
EP3302451B1 (en) Combination comprising palmitoylethanolamide (pea) and lycopene for use in the treatment of inflammatory diseases
Martin Multimodal care for headaches, lumbopelvic pain, and dysmenorrhea in a woman with endometriosis: a case report
US9662361B1 (en) Method for treating azoospermia
KR102195761B1 (en) Methods for alleviating symptoms of multiple sclerosis based on apoaequorin-containing compositions
CN100525792C (en) Chinese medicine composition for treating angiitis and phlebitis
RU2517217C1 (en) Agent for preventing chronic fatigue syndrome in males
Madaeva et al. Melatonin in therapy of sleep disorders age-related estrogen deficiency
CN109464451B (en) Medicine for treating neurasthenia and preparation method thereof
CN100457150C (en) Capsule or tablet for relieving vision fatigue and preparing method
EP4005564A1 (en) Treatment for hot flushes, and re-establishing a menstrual cycle during the perimenopause
Anisha Ayurvedic management of Premenstrual Syndrome-A Case Study
KR101901630B1 (en) Pharmaceutical composition for prevention or tretment of pruritus comprising leaf of sanjook, flower of marigold, root of chinese catbrier and root of curly dock, and manufacturing method thereof
CN104398898A (en) Preparation method for climacteric hyperthyroidism ion penetration agent
CN107569577A (en) A kind of application of pharmaceutical composition in the medicine for preparing treatment trigeminal neuralgia
WO2020024246A1 (en) Ear drops used for tinnitus and with ear health and relief functions
Brown et al. An update on the treatment of premenstrual syndrome
CN107441219B (en) A kind of pharmaceutical composition for improving AIDS immune function and application thereof
CN106977583A (en) A kind of oligopeptides and preparation method and application
English Arginine and select phytonutrients enhance libido
CN109954052A (en) A kind of composition with antioxidant activity
RU2464816C1 (en) Biologically active substances composition with geroprotective activity and method for complex correction of age-related changes of hormonal balance, epiphysis functions and antioxidant status involving said composition administration

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant